{
    "eid": "2-s2.0-85110377771",
    "title": "Targeting the pi3k/akt/mtor signaling pathway in lung cancer: An update regarding potential drugs and natural products",
    "cover-date": "2021-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Analytical Chemistry",
            "@code": "1602",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemistry (miscellaneous)",
            "@code": "1601",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Physical and Theoretical Chemistry",
            "@code": "1606",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "Mammalian target of rapamycin (mTOR)",
        "Natural compounds",
        "Phosphatidylinositol\u20103\u2010kinase (PI3K)",
        "Protein kinase B (PKB/AKT)"
    ],
    "authors": [
        " Iksen",
        "Sutthaorn Pothongsrisit",
        "Varisa Pongrakhananon"
    ],
    "citedby-count": 58,
    "ref-count": 240,
    "ref-list": [
        "Cancer Progression Is Mediated by Proline Catabolism in Non\u2010Small Cell Lung Cancer",
        "Systemic Therapy for Locally Advanced and Metastatic Non\u2010Small Cell Lung Cancer: A Review",
        "Non\u2010Small Cell Lung Cancer: Current Treatment and Future Advances",
        "LncRNA MAGI2\u2010AS3 Upregulates Cytokine Signaling 1 by Sponging MiR\u2010155 in Non\u2010Small Cell Lung Cancer",
        "Lung Cancer: A Review",
        "Targeted Therapy for Squamous Cell Lung Cancer",
        "The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours",
        "Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non\u2010Small Cell Lung Cancer",
        "The Significant Impact of Chemotherapy in Lung Cancer",
        "Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non\u2010Small Cell Lung Cancer",
        "Interleukin\u20107 Resensitizes Non\u2010Small\u2010Cell Lung Cancer to Cisplatin via Inhibition of ABCG2",
        "Targeted Therapy and Immunotherapy for Lung Cancer",
        "Lung Cancer: Biology and Treatment Options",
        "Drug Resistance in Non\u2010Small Cell Lung Cancer: A Potential for NOTCH Targeting?",
        "Chemotherapy for Lung Cancer in the Era of Personalized Medicine",
        "Cisplatin Resistance and Opportunities for Precision Medicine",
        "Chemotherapy Resistance in Lung Cancer",
        "Targeted Therapy vs Chemotherapy: Which Has Had More Impact on Survival in Lung Cancer?\u2014Hematology & Oncology",
        "Successes and Limitations of Targeted Cancer Therapy in Lung Cancer",
        "New Molecular Targets in the Treatment of NSCLC",
        "A Phase Ib Trial of Continuous Once\u2010Daily Oral Afatinib plus Sirolimus in Patients with Epidermal Growth Factor Receptor Mu-tation\u2010Positive Non\u2010Small Cell Lung Cancer and/or Disease Progression Following Prior Erlotinib or Gefitinib",
        "Sotetsuflavone Suppresses Invasion and Metastasis in Non\u2010Small\u2010Cell Lung Cancer A549 Cells by Reversing EMT via the TNF\u2010\u03b1/NF\u2010\u039aB and PI3K/AKT Signaling Pathway",
        "Tripchlorolide Induces Autophagy in Lung Cancer Cells by Inhibiting the PI3K/AKT/MTOR Pathway and Improves Cisplatin Sensitivity in A549/DDP Cells",
        "Antitumor Activity of Curcumin by Modulation of Apoptosis and Autophagy in Human Lung Cancer A549 Cells through Inhibiting PI3K/Akt/MTOR Pathway",
        "The Diverse Mechanisms and Anticancer Potential of Naph-thoquinones",
        "Reprogramming of Fatty Acid Metabolism in Cancer",
        "The Evolution of Phosphatidylinositol 3\u2010Kinases as Regulators of Growth and Metabolism",
        "The Phosphoinositide 3\u2010Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Im-plications",
        "Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers or Dimers",
        "Protein Tyrosine Kinase Structure and Function",
        "Regulation and Targets of Receptor Tyrosine Kinases",
        "Requirement of Phosphatidylinositol(3,4,5)Trisphosphate in Phosphatidylinositol 3\u2010Kinase\u2010Induced Oncogenic Transformation",
        "PTEN and the PI3\u2010Kinase Pathway in Cancer",
        "Active Form of AKT Controls Cell Proliferation and Response to Apoptosis in Hepatocellular Carcinoma",
        "Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor",
        "Metastasis and AKT Activation",
        "PI3K/AKT/MTOR Pathway in Angiogenesis",
        "The LKB1 Tumor Suppressor Negatively Regulates MTOR Signaling",
        "TSC2 Is Phosphorylated and Inhibited by Akt and Suppresses MTOR Signalling",
        "Inactivation of the Tuberous Sclerosis Complex\u20101 and \u20102 Gene Products Occurs by Phosphoinosi-tide 3\u2010Kinase/Akt\u2010Dependent and \u2010Independent Phosphorylation of Tuberin",
        "MTOR Signaling in Cancer and Mtor Inhibitors in Solid Tumor Targeting Therapy",
        "MTOR Signaling Pathway and MTOR Inhibitors in Cancer: Progress and Challenges",
        "MTORC1 and MTORC2 in Cancer and the Tumor Microenvironment",
        "MTORC2 Regulates Mechanically Induced Cytoskeletal Reorganization and Lineage Selection in Marrow\u2010Derived Mesenchymal Stem Cells",
        "The Mammalian Target of Rapamycin\u2010 Signaling Pathway in Regulating Metabolism and Growth",
        "Upstream and Downstream of MTOR",
        "Rheb Activation of MTOR and S6K1 Signaling",
        "PI3K Pathway Alterations in Cancer: Variations on a Theme",
        "PIK3CA Mutation Profiling in Patients with Breast Cancer, Using a Highly Sensitive Detection System",
        "PI3K/AKT/MTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?",
        "Clinical Significance of PIK3CA Gene in Non\u2010Small\u2010Cell Lung Cancer: A Systematic Review and Meta\u2010Analysis",
        "Effects of Oncogenic P110\u03b1 Subunit Mutations on the Lipid Kinase Activity of Phosphoinositide 3\u2010 Kinase",
        "Identification of Allosteric Binding Sites for PI3K\u03b1 Oncogenic Mutant Specific Inhibitor Design",
        "Insights into the Mechanism of the PIK3CA E545K Activating Mutation Using MD Simulations",
        "Tissue Transglutaminase Regulates Focal Adhesion Kinase/AKT Activation by Modulating PTEN Expression in Pancreatic Cancer Cells",
        "Targeting PI3K in Cancer: Mechanisms and Advances in Clinical Trials 06 Biological Sciences 0601 Biochemistry and Cell Biology",
        "PTEN: Multiple Functions in Human Malignant Tumors",
        "Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis",
        "Dysregulations in the PI3K Pathway and Targeted Therapies for Head and Neck Squamous Cell Carcinoma",
        "Akt Phosphorylation and Stabilization of X\u2010Linked Inhibitor of Apoptosis Protein (XIAP)",
        "A Phosphatidylinositol 3\u2010Kinase/Akt Pathway Promotes Translocation of Mdm2 from the Cytoplasm to the Nucleus",
        "Cross\u2010Talk between Akt, P53 and Mdm2: Possible Implications for the Regulation of Apoptosis",
        "Mdm2 Inhibition Induces Apoptosis in P53 Deficient Human Colon Cancer Cells by Activating P73\u2010 and E2F1\u2010Mediated Expression of PUMA and Siva\u20101",
        "Interplay between FOXO, TOR, and Akt",
        "PI3K/AKT Pathway as a Key Link Modulates the Multidrug Resistance of Cancers",
        "The BCL\u20102 Arbiters of Apoptosis and Their Growing Role as Cancer Targets",
        "Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cyto-chrome c from Mitochondria",
        "Akt Phosphorylation of BAD Couples Survival Signals to the Cell\u2010 Intrinsic Death Machinery",
        "Targeting of X\u2010Linked Inhibitor of Apoptosis Protein and PI3\u2010Kinase/AKT Signaling by Embelin Suppresses Growth of Leukemic Cells",
        "X\u2010 Chromosome\u2010Linked Inhibitor of Apoptosis as a Key Factor for Chemoresistance in Clear Cell Carcinoma of the Ovary",
        "Mdm2\u2010Mediated Ubiquitylation: P53 and Beyond",
        "Functional Role of Mdm2 Phosphorylation by ATR in Attenuation of P53 Nuclear Export",
        "Pharmacologic Activation of P53 Elicits Bax\u2010Dependent Apoptosis in the Absence of Transcription",
        "How Does P53 Induce Apoptosis and How Does This Relate to P53\u2010 Mediated Tumour Suppression?",
        "Akt, FoxO and Regulation of Apoptosis",
        "Inhibition of AKT Promotes FOXO3a\u2010Dependent Apoptosis in Prostate Cancer",
        "FoxO Transcription Factors; Regulation by AKT and 14\u20103\u20103 Proteins",
        "Targeting the PI3K\u2010AKT\u2010MTOR Singnaling Network in Cancer",
        "MTOR Signaling in Growth, Metabolism, and Disease",
        "P21 and P27: Roles in Carcinogenesis and Drug Resistance",
        "MTOR: Role in Cancer, Metastasis and Drug Resistance",
        "Role of MTOR Signaling in Tumor Cell Motility, Invasion and Metastasis",
        "Role of AKT and MTOR Signaling Pathways in the Induction of Epithelial\u2010Mesenchymal Transition (EMT) Process",
        "Migration and Epithelial\u2010to\u2010Mesenchymal Transition of Lung Cancer Can Be Targeted via Translation Initiation Factors EIF4E and EIF4GI",
        "Phosphorylation of EIF4E Promotes EMT and Metastasis via Translational Control of SNAIL and MMP\u20103",
        "PI3K Induced Actin Filament Remodeling through Akt and P70S6K1: Implication of Essential Role in Cell Migration",
        "The Actin\u2010Bundling Protein Palladin Is an Akt1\u2010Specific Substrate That Regulates Breast Cancer Cell Mi-gration",
        "P70 S6 Kinase and Actin Dynamics",
        "P70 S6 Kinase in the Control of Actin Cytoskeleton Dynamics and Directed Migration of Ovarian Cancer Cells",
        "Ascofuranone Suppresses Invasion and F\u2010Actin Cytoskeleton Organization in Cancer Cells by Inhibiting the MTOR Complex 1 Signaling Pathway",
        "Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis",
        "Activation of P70S6K Induces Expression of Matrix Metalloproteinase 9 Associated with Hepatocyte Growth Factor\u2010Mediated Invasion in Human Ovarian Cancer Cells",
        "Erianthridin Suppresses Non\u2010Small\u2010Cell Lung Cancer Cell Metastasis through Inhibition of Akt/MTOR/P70S6K Signaling Pathway",
        "EIF4E Phosphorylation Promotes Tumorigenesis and Is Associated with Prostate Cancer Progression",
        "Overview of Angiogenesis",
        "Unraveling the Role of Angiogenesis in Cancer Ecosystems",
        "Stabilization of Hypoxia\u2010Inducible Factor\u20101\u03b1 Protein in Hypoxia Occurs Independently of Mitochondrial Reactive Oxygen Species Production",
        "HIF\u20101\u03b1 Pathway: Role, Regulation and Intervention for Cancer Therapy",
        "Hypoxia/Pseudohypoxia\u2010Mediated Activation of Hypoxia\u2010Inducible Factor\u20101\u03b1 in Cancer",
        "Hypoxia\u2010Induced Angiogenesis: Good and Evil",
        "The Role of Hypoxia Inducible Factor\u20101\u03b1 in the Increased MMP\u20102 and MMP\u20109 Production by Human Monocytes Exposed to Nickel Nanoparticles",
        "Matrix Metalloproteinases in Angiogenesis: A Moving Target for Therapeutic Intervention",
        "The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward",
        "\u03b1\u2010Santalol Inhibits the Angiogenesis and Growth of Human Prostate Tumor Growth by Targeting Vascular Endothelial Growth Factor Receptor 2\u2010Mediated AKT/mTOR/P70S6K Signaling Pathway",
        "Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF\u20101\u03b1 Protein Accumulation and VEGF Expression through PI3K/AKt/P70S6K and ERK1/2 Signaling Pathways in Non\u2010Small Cell Lung Cancer Cells",
        "Advances in Subunits of PI3K Class I in Cancer",
        "Structural Comparisons of Class I Phos-phoinositide 3\u2010Kinases",
        "Structural Determinants of Isoform Selectivity in Pi3k Inhibitors",
        "The Structural Basis of PI3K Cancer Mutations: From Mechanism to Therapy",
        "Molecular Determinants of PI3K\u03b3\u2010Mediated Activation Downstream of G\u2010Protein\u2010Coupled Receptors (GPCRs)",
        "Isoform Selective PI3K Inhibitors for Treating Cancer",
        "PI3K Inhibitors: Review and New Strategies",
        "Targeting the PI3K Pathway in Cancer: Are We Making Headway?",
        "Identification of NVP\u2010BKM120 as a Potent, Selective, Orally Bioavailable Class i PI3 Kinase Inhibitor for Treating Cancer",
        "Class I Phosphatidylinositol 3\u2010Kinase Inhibitors for Cancer Therapy",
        "Phase I Dose\u2010Escalation and \u2010Expansion Study of Buparlisib (BKM120), an Oral Pan\u2010Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors",
        "The Identification of 2\u2010(1H\u2010Indazol\u20104\u2010Yl)\u20106\u2010(4\u2010Methanesulfonyl\u2010Piperazin\u20101\u2010 Ylmethyl)\u20104\u2010Morpholin\u20104\u2010Yl\u2010Thieno[3,2\u2010 d]Pyrimidine (GDC\u20100941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer",
        "First-in\u2010Human Phase I Study of Pictilisib (GDC\u20100941), a Potent Pan\u2010Class I Phosphatidylinositol\u20103\u2010Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors",
        "A Phase IB Dose\u2010Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Either Paclitaxel and Carboplatin (with or without Bevacizumab) or Pemetrexed and Cisplatin (with or without Bevacizumab) in Patients with Advanced Non\u2013 Small Cell Lung Cancer",
        "CAL\u2010101, a P110\u03b4 Selective Phosphatidylinositol\u20103\u2010Kinase Inhibitor for the Treatment of B\u2010Cell Malignan-cies, Inhibits PI3K Signaling and Cellular Viability",
        "Idelalisib",
        "Discovery of NVP\u2010BYL719 a Potent and Selective Phosphatidylinositol\u20103 Kinase Alpha Inhibitor Selected for Clinical Evalu-ation",
        "Characterization of the Novel and Specific PI3Ka Inhibitor NVP\u2010BYL719 and Development of the Patient Strat-ification Strategy for Clinical Trials",
        "Alpelisib plus Fulvestrant for PIK3CA\u2010Mutated, Hormone Receptor\u2010Positive, Human Epidermal Growth Factor Receptor\u2010 2\u2013Negative Advanced Breast Cancer: Final Overall Survival Results from SOLAR\u20101",
        "A Phase 1b Dose\u2010Escalation Study of BYL719 plus Binimetinib (MEK162) in Patients with Selected Advanced Solid Tumors",
        "A First\u2010in\u2010Human, Phase I, Dose\u2010Escalation Study of TAK\u2010117, A Selective PI3Ka Isoform Inhibitor, in Patients with Advanced Solid Malignancies",
        "Discovery of 2\u2010{3\u2010[2\u2010(1\u2010Isopropyl\u20103\u2010Methyl\u20101H\u20101,2\u20104\u2010Triazol\u20105\u2010Yl)\u20105,6\u2010 Dihydrobenzo[f]Imidazo[1,2\u2010 d ][1,4]Oxazepin\u20109\u2010 Yl]\u20101H\u2010Pyrazol\u20101\u2010Yl}\u20102\u2010 Methylpropanamide (GDC\u20100032): A \u03b2\u2010Sparing Phosphoinositide 3\u2010Kinase Inhibitor with High Un-bound Exposure and Robust in Vivo Antitumor Activity",
        "SWOG S1400B (NCT02785913), a Phase II Study of GDC\u20100032 (Taselisib) for Previously Treated PI3K\u2010Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung\u2010MAP Sub\u2010Study)",
        "Bis(Morpholino\u2010l,3,5\u2010Triazine) Derivatives: Potent Adenosine 5\u2032\u2010Triphosphate Competitive Phosphatidylinositol\u20103\u2010Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI\u2010587), a Highly Efficacious Dual Inhibitor",
        "PKI\u2010179: An Orally Efficacious Dual Phosphatidylinositol\u20103\u2010Kinase (PI3K)/Mammalian Target of Ra-pamycin (MTOR) Inhibitor",
        "Drug Discovery Approaches Targeting the PI3K/Akt Pathway in Cancer",
        "Synergistic Antitumor Effects of Combination PI3K/MTOR and MEK Inhibition (SAR245409 and Pimasertib) in Mucinous Ovarian Carcinoma Cells by Fluorescence Resonance Energy Transfer Imaging",
        "AKT Crystal Structure and AKT\u2010Specific Inhibitors",
        "Control of Akt Activity and Substrate Phosphorylation in Cells",
        "The Structural Determinants of Ph Domain\u2010Mediated Regulation of Akt Revealed by Segmental Labeling",
        "Conformational Sampling of Membranes by Akt Controls Its Activation and Inactivation",
        "Autoregulation of Kinase Dephosphorylation by ATP Binding to AGC Protein Kinases",
        "Inhibitors in AKTion: ATP\u2010Competitive vs Allosteric",
        "An ATP\u2010Site on\u2010off Switch That Restricts Phosphatase Accessibility of Akt",
        "Harnessing Allostery: A Novel Approach to Drug Discovery",
        "Phase II Study of the AKT Inhibitor MK\u20102206 plus Erlotinib in Patients with Advanced Non\u2010Small Cell Lung Cancer Who Previously Progressed on Erlotinib",
        "Abstract #DDT01\u20101: MK\u20102206: A Potent Oral Allosteric AKT Inhibitor",
        "MK\u20102206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs in Vitro and in Vivo",
        "First\u2010in\u2010Man Clinical Trial of the Oral Pan\u2010AKT Inhibitor MK\u2010206 in Patients with Advanced Solid Tumors",
        "Phase 1 Trial of the Oral AKT Inhibitor MK\u20102206 plus Carboplatin/ Paclitaxel, Docetaxel, or Erlotinib in Patients with Advanced Solid Tumors",
        "Erlotinib as Second\u2010 Line Treatment in Patients with Advanced Non\u2010Small\u2010Cell Lung Cancer and Asymptomatic Brain Metastases: A Phase II Study (CTONG\u20100803)",
        "Discovery of 4\u2010Amino\u2010N\u2010[(1S)\u20101\u2010(4\u2010Chlorophenyl)\u20103\u2010Hydroxypropyl]\u20101\u2010(7H\u2010 Pyrrolo[2,3\u2010d]Pyrimidin\u20104\u2010Yl)Piperidine\u20104\u2010Car-boxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases",
        "A Phase I Dose\u2010Escalation Study of Enzalutamide in Combination with the AKT Inhibitor AZD5363 (Capi-vasertib) in Patients with Metastatic Castration\u2010Resistant Prostate Cancer",
        "A Putative Biomarker Signature for Clinically Effective AKT Inhibition: Correlation of in Vitro, in Vivo and Clinical Data Identifies the Importance of Modulation of the MTORC1 Pathway",
        "Phase I Dose\u2010Escalation Trial of the Oral AKT Inhibitor Uprosertib in Combination with the Oral MEK1/MEK2 Inhibitor Trametinib in Patients with Solid Tumors",
        "Perifosine, a Novel Alkylphospholipid, Induces P21WAF1 Expression in Squamous Carcinoma Cells through a P53\u2010Independent Pathway, Leading to Loss in Cyclin\u2010Depend-ent Kinase Activity and Cell Cycle Arrest",
        "Results of the X\u2010PECT Study: A Phase III Randomized Double\u2010Blind, Placebo\u2010Controlled Study of Perifosine plus Capecitabine (P\u2010CAP) versus Placebo plus Capecitabine (CAP) in Patients (Pts) with Refractory Metastatic Colorectal Cancer (MCRC)",
        "Aspirin Sensitizes Osimertinib\u2010Resistant NSCLC Cells in Vitro and in Vivo via Bim\u2010Dependent Apoptosis Induction",
        "Aspirin Has a Better Effect on PIK3CA Mutant Colorectal Cancer Cells by PI3K/Akt/Raptor Pathway",
        "Aspirin Inhibits MTOR Signaling, Activates AMP\u2010Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells",
        "Targeting MTOR for Cancer Therapy",
        "4.4 \u00c5 Resolution Cryo\u2010EM Structure of Human MTOR Complex 1",
        "Regulation of Mtorc1 by Upstream Stimuli",
        "Structural Insights of MTOR Complex 1",
        "A Novel Rapamycin Analog Is Highly Selective for MTORC1 in Vivo",
        "ATP\u2010Competitive Inhibitors of MTOR: An Update",
        "NVP\u2010BEZ235, a Novel Dual PI3K\u2010MTOR Inhibitor Displays Anti\u2010Glioma Activity and Reduces Chemoresistance to Temozolomide in Human Glioma Cells",
        "Dual PI3K/MTOR Inhibitor BEZ235 as a Promising Therapeutic Strategy against Paclitaxel\u2010Resistant Gastric Cancer via Targeting PI3K/Akt/MTOR Pathway Article",
        "Inhibition of MTOR by Temsirolimus Contributes to Prolonged Survival of Mice with Pleural Dissemination of Non\u2010 Small\u2010Cell Lung Cancer Cells",
        "A Phase i Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non\u2010Small Cell Lung Cancer",
        "A Phase i Study of Temsirolimus and Thoracic Radiation in Non\u2010Small\u2010Cell Lung Cancer",
        "The Journey of Metformin from Glycaemic Control to MTOR Inhibition and the Suppression of Tumour Growth",
        "Metformin Use and Survival after Non\u2010Small Cell Lung Cancer: A Cohort Study in the US Military Health System",
        "Survival Benefit Associated with Metformin Use in Inoperable Non\u2010Small Cell Lung Cancer Patients with Diabetes: A Population\u2010Based Retrospective Cohort Study",
        "CC\u2010223, a Potent and Selective Inhibitor of MTOR Kinase: In Vitro and in Vivo Characterization",
        "Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopre-ventive Agents",
        "Natural Products as Reservoirs of Novel Therapeutic Agents",
        "A Historical Overview of Natural Products in Drug Discovery",
        "A New Bibenzyl from Dendrobium Secundum",
        "Recent Research Progress on Natural Small Molecule Bibenzyls and Its Derivatives in Dendrobium Species",
        "A Bibenzyl from Dendrobium Ellipsophyl-lum Induces Apoptosis in Human Lung Cancer Cells",
        "A Bibenzyl from Dendrobium Ellipsophyllum Inhibits Migration in Lung Cancer Cells",
        "A Bibenzyl from Dendrobium Ellipsophyllum Inhibits Epithelial\u2010to\u2010Mesenchymal Transition and Sensitizes Lung Cancer Cells to Anoikis",
        "Cytotoxic and Anti\u2010Metastatic Activities of Phenolic Compounds from Dendrobium Ellipsophyllum",
        "Gigantol, a Bibenzyl from Dendrobium Draconis, Inhibits the Migratory Behavior of Non\u2010Small Cell Lung Cancer Cells",
        "Gigantol Targets Cancer Stem Cells and Destabilizes Tumors via the Suppression of the PI3K/AKT and JAK/STAT Pathways in Ectopic Lung Cancer Xenografts",
        "Gigantol Inhibits Epithelial to Mesenchymal Process in Human Lung Cancer Cells",
        "The Attenuation of Epithelial to Mesenchymal Transition and Induction of Anoikis by Gigantol in Human Lung Cancer H460 Cells",
        "Natural Phenanthrenes and Their Biological Activity",
        "Phenanthrenes: A Promising Group of Plant Secondary Metabolites",
        "Ephemeranthol a Suppresses Epithelial to Mesenchymal Transition and FAK\u2010Akt Signaling in Lung Cancer Cells",
        "Cypripedin, a Phenanthrenequinone from Dendrobium Den-siflorum, Sensitizes Non\u2010Small Cell Lung Cancer H460 Cells to Cisplatin\u2010Mediated Apoptosis",
        "Cypripedin Diminishes an Epithelial\u2010to\u2010Mesenchymal Transition in Non\u2010Small Cell Lung Cancer Cells through Suppression of Akt/GSK\u20103\u03b2 Signalling",
        "Erianthridin Induces Non\u2010Small Cell Lung Cancer Cell Apoptosis through the Suppression of Extracellular Signal\u2010Regulated Kinase Activity",
        "Chemistry and Biological Activities of Flavonoids: An Overview",
        "Phoyunnanin e Induces Apoptosis of Non\u2010Small Cell Lung Cancer Cells via P53 Activation and down\u2010Regulation of Survivin",
        "Phoyunnanin E Inhibits Migration of Non\u2010Small Cell Lung Cancer Cells via Suppression of Epithelial\u2010to\u2010Mesenchymal Transition and Integrin \u0391v and Integrin \u03923",
        "Curcumin: A Review of Its Effects on Human Health",
        "Curcumin Inhibits Cell Proliferation and Induces Apoptosis of Human Non\u2010Small Cell Lung Cancer Cells through the Upregulation of MiR\u2010192\u20105p and Suppression of PI3K/Akt Signaling Pathway",
        "Curcumin Inhibits Migration and Invasion of Non\u2010Small Cell Lung Cancer Cells through up\u2010Regulation of MiR\u2010206 and Suppression of PI3K/AKT/MTOR Signaling Pathway",
        "Biological and Chemical Aspects of Natural Biflavonoids from Plants: A Brief Review",
        "Sotetsuflavone Inhibits Proliferation and Induces Apoptosis of A549 Cells through ROS\u2010Mediated Mitochondrial\u2010Dependent Pathway",
        "Sotetsuflavone Induces Autophagy in Non\u2010Small Cell Lung Cancer through Blocking PI3K/Akt/MTOR Signaling Pathway in Vivo and in Vitro",
        "Luteoloside Induces G0/G1 Arrest and pro\u2010Death Autophagy through the ROS\u2010Mediated AKT/MTOR/P70S6K Signalling Pathway in Human Non\u2010Small Cell Lung Cancer Cell Lines",
        "An Overview on Cardamonin",
        "Cardamonin Inhibits the Proliferation and Metastasis of Non\u2010Small\u2010Cell Lung Cancer Cells by Suppressing the PI3K/Akt/MTOR Pathway",
        "FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline\u2010 Containing Regimen",
        "Chemistry of Renieramycins. 15. Synthesis of 22\u2010 O \u2010Ester Derivatives of Jorunnamycin A and Their Cytotoxicity against Non\u2010Small\u2010Cell Lung Cancer Cells",
        "Jorunnamycin A from Xestospongia Sp. Suppresses Epithelial to Mesenchymal Transition and Sensitizes Anoikis in Human Lung Cancer Cells",
        "Chemistry of Renieramy-cins. Part 3. Isolation and Structure of Stabilized Renieramycin Type Derivatives Possessing Antitumor Activity from Thai Sponge Xestospongia Species, Pretreated with Potassium Cyanide",
        "Renieramycin M Attenuates Cancer Stem Cell\u2010like Phe-notypes in H460 Lung Cancer Cells",
        "Renieramycin M Sensitizes Anoikis\u2010Resistant H460 Lung Cancer Cells to Anoikis",
        "Anticancer and Antimetastatic Activities of Renieramyein M, a Marine Tetrahydroisoquinoline Alkaloid, in Human Non\u2010Small Cell Lung Cancer Cells"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Medan",
            "@id": "60189250",
            "affilname": "Sekolah Tinggi Ilmu Kesehatan Senior Medan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60189250",
            "affiliation-country": "Indonesia"
        }
    ],
    "funding": [
        "Ratchadaphiseksomphot Endowment Fund",
        "Second Century Fund",
        "Chulalongkorn University"
    ]
}